Supply problems of unlicensed and off-label medicines after discharge

Archives of Disease in Childhood

Volumn 91, Issue 8, 2006, Pages 686-688

  Wong, I C K ^a   Basra, N ^a   Yeung, V W ^a   Cope, Judith ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; HOSPITAL DISCHARGE; HUMAN; INFANT; INTERVIEW; NEWBORN; OFF LABEL DRUG USE; PEDIATRIC HOSPITAL; PHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNITY PHARMACY SERVICES; DRUG LABELING; FAMILY PRACTICE; HUMANS; INFANT; INFANT, NEWBORN; LONDON; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 33746890866     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.093724     Document Type: Article

References (5)

1. Wong ICK, Sweis D, Cope J, Florence A. Children's medicines research in the UK - how to move forward? Drug Safety 2003;26:529-37.
2. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary No. 47. London: British Medical Association, Royal Pharmaceutical Society of Great Britain, 2004.
3. Electronic Medicines Compendium. http://emc.medicines.org.uk/(accessed 21 September 2005).
4. BPA, ABPI. Licensing medicines for children. A report of the joint working party of the British Paediatric Association and the Association of the British Pharmaceutical Industry on the development of medicines for children. London: British Paediatric Association, 1996.
5. European Commission. Proposal for a Regulation of the Council and of the Parliament on Medicinal Products for Paediatric Use. http://pharmacos. eudra.org/F2/Paediatrics/index.htm (accessed 21 September 2005).